| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Jamie K Capal, MD |
Secondary Analyses: The Effects of Epileptogenesis on ASD Clinical Phenotypes |
Massachusetts General Hospital (Health Resources & Services Admin) |
226859 |
9/1/2017 - 8/31/2018 |
$15,000 |
| Donald L Gilbert, MD |
GABAergic Sensorimotor Dysfunction in Tourette Syndrome |
Kennedy Krieger Research Institute (National Institutes of Health (NIH)) |
113091-0319 |
4/1/2018 - 3/31/2019 |
$189,960 |
| Donald L Gilbert, MD |
Is Procedural Memory Enhanced in Tourette Syndrome? |
Georgetown University Medical Center (Tourette Association of America) |
412681_GR412622_CCHM |
10/1/2018 - 9/30/2019 |
$10,093 |
| Donald L Gilbert, MD |
Collaborative Genomic Studies of Tourette Disorder |
National Institutes of Health (NIH) |
1R01MH115962-01 |
4/1/2019 - 3/31/2020 |
$238,500 |
| Tracy A Glauser, MD |
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT) |
University of Cincinnati (National Institutes of Health (NIH)) |
011609-002 |
7/1/2018 - 6/30/2019 |
$159,000 |
| Christina Gross, PHD |
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy |
National Institutes of Health (NIH) |
R01NS092705 |
1/1/2019 - 12/31/2019 |
$341,250 |
| Christina Gross, PHD |
Mechanism-based treatment targets and biomarkers for genetically defined mental illnesses |
Brain & Behavior Research Foundation |
25746 |
9/15/2018 - 9/14/2019 |
$50,000 |
| Christina Gross, PHD |
Mechanism-targeted treatment strategy in PTEN-associated autism and epilepsy |
National Institutes of Health (NIH) |
1R21HD093033-01A1 |
6/1/2019 - 5/31/2020 |
$402,048 |
| Christina Gross, PHD |
FMR1 Gene Therapy for Fragile X Syndrome |
FRAXA Research Foundation |
FRAXA_Gross |
5/1/2019 - 4/30/2020 |
$45,000 |
| Andrew D Hershey, MDPHD |
Pediatric Migraine Registry Duke Univ/FDA |
Duke University (Food and Drug Administration) |
234691/240919 |
12/4/2018 - 8/31/2019 |
$5,989 |
| Darren Kadis, PHD |
MEG Connectivity-Based Mapping of Critical Language Site |
National Institutes of Health (NIH) |
R21NS106631 |
9/15/2018 - 8/31/2019 |
$223,615 |
| Darcy Krueger, MD |
Early biomarkers of Autism Spectrum Disorders in infants |
Children's Hospital Boston (National Institutes of Health (NIH)) |
GENFD0001563311 |
9/1/2017 - 8/31/2019 |
$55,434 |
| Darcy Krueger, MD |
Early biomarkers of Autism Spectrum Disorders in infants |
Children's Hospital Boston (National Institutes of Health (NIH)) |
GENFD0001563295 |
9/1/2016 - 8/31/2019 |
$6,949 |
| Darcy Krueger, MD |
Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations |
Children's Hospital Boston (National Institutes of Health (NIH)) |
GENFD0001329656 |
8/1/2018 - 7/31/2019 |
$79,259 |
| Darcy Krueger, MD |
Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis Comples |
University of Alabama-Birmingham (National Institutes of Health (NIH)) |
000510297-001 |
6/1/2018 - 5/31/2019 |
$196,359 |
| Matthew R Skelton, PHD |
Identifying critical periods for creatine in brain development |
Association for Creatine Deficiencies |
CARE001 |
8/1/2018 - 7/31/2019 |
$5,000 |
| John Michael Taylor |
The Vascular Effects of Infection in Pediatric Stroke (VIPS II) Study |
The Univ of California, San Francisco (National Institutes of Health (NIH)) |
11258sc |
3/31/2019 - 6/30/2019 |
$11,766 |
| Cameron W Thomas, MD |
Continued Anticonvulsants after Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study |
University of Michigan (Patient-Centered Outcome Research Inst.) |
SUBK00007861 |
7/1/2017 - 6/30/2020 |
$1,600 |
| Cameron W Thomas, MD |
Spasm Prediction after Symptomatic Neonatal Seizures - the SPASM study |
University of Michigan (Pediatric Epilepsy Research Fdn) |
3005082503 |
9/1/2017 - 8/31/2019 |
$9,000 |
| Cuixia Tian, MD |
MDA Care Center Grant |
Muscular Dystrophy Association |
492633 |
1/1/2019 - 12/31/2019 |
$50,000 |
| Cuixia Tian, MD |
PPMD Grant Award 2019 for Cincinnati Children's Certified Duchenne Care Center |
Parent Project Muscular Dystrophy |
Tian_PPMD |
1/1/2019 - 12/31/2019 |
$10,000 |
| Lubov Timchenko, PHD |
GSK3 Beta Study in Patients with Myotonic Dystrophy 1 |
National Institutes of Health (NIH) |
R01AR073379 |
1/15/2019 - 12/31/2019 |
$447,079 |
| Jennifer J Vannest, PHD |
A Preliminary Study of the Neurobiology of AAC-Induced Language Recovery in Post-Stroke Aphasia |
University of Cincinnati (National Institutes of Health (NIH)) |
011760-003 |
9/1/2018 - 8/31/2019 |
$187,902 |
| Jennifer J Vannest, PHD |
Multimodal Neuroimaging Distinguishes Developmental and Disordered Phenotypes in Speech Sound Disorders |
National Institutes of Health (NIH) |
R21DC017393 |
4/1/2019 - 3/31/2020 |
$251,047 |
| Charles V Vorhees, PHD |
LPHN3: Function and Role in ADHD |
The Local Initiative for Excellence Fdtn |
LIFE_Vorhees |
9/18/2018 - 9/17/2019 |
$50,000 |
| Steve Wu, MD |
Cortical Neurophysiologic Biomarkers Related to Response Inhibition in Tourette Syndrome |
Tourette Association of America |
TSA_Wu |
12/11/2018 - 12/10/2019 |
$75,000 |
| Jing Xiang, MD-PHD |
Neuromagnetic High Frequency Oscillations to Guide Epilepsy Surgery |
National Institutes of Health (NIH) |
R21NS104459 |
8/1/2018 - 7/31/2019 |
$221,189 |
| Current Year Direct |
$3,338,039 |
